13. Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H.
Impact of COVID-19 on global HCV elimination efforts. J Hepatol 2021; 74(1): 31-36.
14. Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PD, Bulabula AN.
Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis 2021; 113: S7-
17. Jha NK, Jeyaraman M, Rachamalla M, Ojha S, Dua K, Chellappan DK, Muthu S, Sharma A, Jha SK, Jain R, Jeyaraman N.
Current understanding of novel coronavirus: molecular pathogenesis, diagnosis, and treatment approaches. Immuno 2021; 1(1): 30-66.
27. Saleem RT, Butt MH, Ahmad A, Amin M, Amir A, Ahsan A, Fayyaz F, Saleem R, Riaz T, Waheed U, Zaman M.
Practices and attitude of self-medication during COVID-19 pandemic in university students with interventional role of pharmacist: a regional analysis. Lat Am J Pharm 2021; 40(8): 1946-1953.
33. Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, Zhang B.
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013; 500(7461): 227-231.
35. Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A.
Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2. EMBO J 2005; 24(8): 1634-1643.
47. Zoufaly A, Poglitsch M, Aberle JH, Hoepler W, Seitz T, Traugott M, Grieb A, Pawelka E, Laferl H, Wenisch C, Neuhold S.
Human recombinant soluble ACE2 in severe COVID-19. Lancet Respirat Med 2020; 8(11): 1154-1158.
51. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA.
Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436(7047): 112-116.
55. Liu PC, Liu X, Li Y, Covington M, Wynn R, Huber R, Hillman M, Yang G, Ellis D, Marando C, Katiyar K.
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells. Cancer Biol Ther 2006; 5(6): 657-664.
60. Lucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD, Morrissey C, Corey E, Montgomery B, Mostaghel E, Clegg N.
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer MetastasisTMPRSS2 Influences Prostate Cancer Metastasis. Cancer Discov 2014; 4(11): 1310-1325.
66. Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, Liu Y, Zhang Q, Zhang P, Wang Y, Wang Q.
Furin: a potential therapeutic target for COVID-19. Iscience 2020; 23(10): 101642.
)
)